Back to Agenda
Part 1: Introduction - Industry Perspectives on HTA Regulation Implementation
Session Chair(s)
Ansgar Hebborn, PhD, MBA
Head - Access Policy Affairs Europe
F. Hoffmann-La Roche AG, Switzerland
Speaker(s)
Ansgar Hebborn, PhD, MBA
F. Hoffmann-La Roche AG, Switzerland
Head - Access Policy Affairs Europe
James Ryan, MSc
AstraZeneca (Global), UK, United Kingdom
Director, Global HTA Policy
Claudine Sapède, PharmD
NOVARTIS INTERNATIONAL, Switzerland
Director, Global HTA Policy
Inka Heikkinen, MBA, MSc
Lundbeck, Denmark
Regulatory Policy Lead
Have an account?